Clinical trial automation software specialist, Formedix has announced expansion of its development and test teams. The Formedix platform helps companies conducting clinical trials to submit studies rapidly,
Formedix enables collaborative working and seamless integration with other systems for rapid end-to-end clinical trials, in real-time. The company’s platform enables pharmaceutical organizations to store, control, and reuse clinical metadata. Its automated processes and API integration functionality allows the rapid design, build, and submission of compliant clinical studies.
By expanding the workforce, Formedix says it can stay abreast of technological breakthroughs and meet greater client demands for the enhancement and advancement of its platform.
The expansion of the development and test teams will allow Formedix to make significant extensions to the existing platform, while working on cutting edge functionality for future developments.
Greg Blincow, Formedixc Development Manager, said “We’re really excited to welcome new talent to our teams. Taking on additional developers and testers will let us really focus on new, innovative functionality, whilst at the same time being able to provide enhancements to the current platform.”
Darren Bill, Head of Operations, added “The industry as a whole is moving towards using automated software solutions to maximize efficiency gains. Over the last two years, demand for the Formedix platform has increased significantly. Growing our teams will enable us to keep up with increased demands, and ensure we can deliver top-notch customer service backed by a leading-edge product.”
Source: Life Science News